JUPITER, Fla., May 12, 2011 /PRNewswire/ -- Stem Cell Assurance, Inc. (SCLZ.PK) announced today that it has filed a General Form for Registration of Securities on Form 10 pursuant to Section 12(g) of the Securities Exchange Act of 1934. The Form 10 includes audited financial statements as of December 31, 2009 and 2010 and for the years then ended. Based upon this filing, effective July 11, 2011, the Company will become an SEC reporting company and will be subject to the requirements of the Exchange Act which will require the Company, among other things, to file annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.
The effectiveness of the Form 10 on July 11, 2011 will facilitate the listing of the Company's shares on stock markets other than the Pink Sheets.
Mark Weinreb, the Company's Chief Executive Officer, stated, "We are very pleased to have made this filing which is another step in the development of our Company as a provider of important stem cell-related services."
About Stem Cell Assurance, Inc.
Stem Cell Assurance, Inc.'s goal is to become a medical center of excellence using cell and tissue regenerative therapy protocols, primarily involving a patient's own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. As more and more cellular therapies become standard of care, the Company believes its strength will be its focus on the unity of medical and scientific explanations for its future clinical procedures and outcomes and its incorporation of adult stem cell collection and storage services for future personal medical applications. The Company also operates a wholly owned subsidiary, Stem Cellutrition™, which plans to offers facial creams and other skin care products.
Tel: (561) 904-6070
Fax: (561) 429-5684
SOURCE Stem Cell Assurance, Inc.